TBPH
Theravance Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · KY
$17.02
−0.12%Forward multiples
Based on analyst estimates
- P/E forward
- 5.89x
- P/E 2026E
- 5.89x
- P/E 2027E
- 9.13x
- P/E 2028E
- 11.20x
- P/S forward
- 9.15x
Trailing multiples
Trailing twelve months
- P/E TTM
- 16.00x
- PEG TTM
- 0.09x
- Price / book
- 3.05x
- Price / sales
- 8.47x
- Price / cash flow
- 17.05x
Enterprise value
- Enterprise value
- $534.6M
- EV / sales
- 5.12x
- EV / EBITDA
- 7.81x
- EV / EBIT
- 114.81x
- Market cap
- $883.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026